Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

The 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10-13, 2016, Guangzhou

Soochit A, Zhang C, Liu J

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences

Therasakvichya S, Kuljarusnont S, Petsuksiri J, Chaopotong P, Achariyapota V, Srichaikul P, Jaishuen A

OBJECTIVE: To evaluate the recurrence rates and patterns of failure in patients with stage I endometrial carcinoma after surgical staging without adjuvant therapy. METHODS: Medical records of 229 patients with stage...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers

Martin JY, Urban RR, Liao JB, Goff BA

OBJECTIVE: Bevacizumab was recently approved by the US Food and Drug Administration for use in recurrent platinum resistant epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011

Patel SC, Frandsen J, Bhatia S, Gaffney D

OBJECTIVE: Evaluate the impact of radiotherapy on cause specific survival (CSS) and overall survival (OS) for stage (I-III) clear cell, mucinous, and endometriod ovarian cancer. METHODS: We analyzed incidence, survival, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer

Lee J, Kim TH, Kim GE, Keum KC, Kim YB

OBJECTIVE: We aimed to assess the efficacy of neoadjuvant chemotherapy followed by surgery (NACT+S), and compared the clinical outcome with that of concurrent chemoradiotherapy (CCRT) in patients with International Federation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research

Lee SJ, Yang A, Wu TC, Hung CF

Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic agents. However, despite the various treatments utilized for the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia

Kawano K, Tsuda N, Nishio S, Yonemoto K, Tasaki K, Tasaki R, Ushijima K

OBJECTIVE: To identify key factors for predicting positive cone margin and appropriate cone length. METHODS: We retrospectively reviewed the margin status of patients who received conization with high grade cervical intraepithelial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer

Paik ES, Kim TJ, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS

OBJECTIVE: The aim of this study was to compare survival outcomes in two groups of patients with recurrent epithelial ovarian cancer (EOC) with initial recurrence detection by cancer antigen 125...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients

Kim HS, Kim TJ, Lee IH, Hong SR

OBJECTIVE: This study aimed to examine the meaning and usefulness of sexually transmitted infection (STI) test when caring for patients who have abnormal cervical cytology and/or positive high-risk human papillomavirus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr